218 related articles for article (PubMed ID: 37334585)
1. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.
Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D
Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585
[TBL] [Abstract][Full Text] [Related]
2. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound pattern of hepatocellular carcinoma in noncirrhotic liver - results from the prospective multicentre DEGUM CEUS HCC study.
Schellhaas B; Jesper D; Strobel D;
Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):313-319. PubMed ID: 36708302
[TBL] [Abstract][Full Text] [Related]
4. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
[TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation.
Schellhaas B; Bernatik T; Dirks K; Jesper D; Mauch M; Potthoff A; Zimmermann P; Strobel D
Ultrasound Med Biol; 2021 Nov; 47(11):3170-3180. PubMed ID: 34417066
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
7. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
8. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
9. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
10. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM Study.
Schellhaas B; Bernatik T; Bohle W; Borowitzka F; Chang J; Dietrich CF; Dirks K; Donoval R; Drube K; Friedrich-Rust M; Gall C; Gittinger F; Gutermann M; Haenle MM; von Herbay A; Ho CH; Hochdoerffer R; Hoffmann T; Hüttig M; Janson C; Jung EM; Jung N; Karlas T; Klinger C; Kornmehl A; Kratzer W; Krug S; Kunze G; Leitlein J; Link A; Lottspeich C; Marano A; Mauch M; Moleda L; Neesse A; Petzold G; Potthoff A; Praktiknjo M; Rösner KD; Schanz S; Schultheiß M; Sivanathan V; Stock J; Thomsen T; Vogelpohl J; Vogt C; Wagner S; Wiegard C; Wiesinger I; Will U; Ziesch M; Zimmermann P; Strobel D
Ultraschall Med; 2021 Apr; 42(2):178-186. PubMed ID: 32663881
[TBL] [Abstract][Full Text] [Related]
12. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.
Schellhaas B; Pfeifer L; Kielisch C; Goertz RS; Neurath MF; Strobel D
Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746
[TBL] [Abstract][Full Text] [Related]
13. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
[TBL] [Abstract][Full Text] [Related]
16. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
18. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
Cheng MQ; Hu HT; Huang H; Pan JM; Xian MF; Huang Y; Kuang M; Xie XY; Li W; Wang W; Lu MD
Eur Radiol; 2021 Aug; 31(8):5680-5688. PubMed ID: 33502556
[TBL] [Abstract][Full Text] [Related]
19. Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging.
Polikoff A; Wessner CE; Balasubramanya R; Dulka S; Liu JB; Machado P; Savsani E; Lyshchik A; Shaw CM; Eisenbrey JR
Abdom Radiol (NY); 2022 Jan; 47(1):152-160. PubMed ID: 34643782
[TBL] [Abstract][Full Text] [Related]
20. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]